Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer
Open Access
- 1 January 2012
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 20 (1), 221-229
- https://doi.org/10.1038/mt.2011.230
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Integrin targeted oncolytic adenoviruses Ad5‐D24‐RGD and Ad5‐RGD‐D24‐GMCSF for treatment of patients with advanced chemotherapy refractory solid tumorsInternational Journal of Cancer, 2011
- Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transferMolecular Genetics and Metabolism, 2003
- Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery.2003
- Overexpression of the ADP (E3-11.6K) Protein Increases Cell Lysis and Spread of AdenovirusVirology, 2003
- Intravascular adenoviral agents in cancer patients: Lessons from clinical trialsCancer Gene Therapy, 2002
- Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints.2002
- Gene Transfer to Ovarian Cancer Versus Normal Tissues with Fiber-Modified AdenovirusesMolecular Therapy, 2002
- Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells.2002
- Genetic Targeting of an Adenovirus Vector via Replacement of the Fiber Protein with the Phage T4 FibritinJournal of Virology, 2001
- Blood clearance rates of adenovirus type 5 in miceJournal of General Virology, 2000